Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC Achieves Partial Remission in a Patient With Progressive Neuroendocrine Liver Metastases After Repeated ß-Emitter Peptide Receptor Radionuclide Therapy.
Clin Nucl Med
; 45(3): 241-243, 2020 Mar.
Article
en En
| MEDLINE
| ID: mdl-31977472
ABSTRACT
We present here a case with ß-radiation-refractory metastatic neuroendocrine tumors, who demonstrated an excellent therapy response after 1 cycle of Ac-DOTATOC, without any significant adverse effects even after 10 cycles of ß-emitter peptide receptor radionuclide therapy followed by α-peptide receptor radionuclide therapy.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Octreótido
/
Actinio
/
Receptores de Péptidos
/
Tumores Neuroendocrinos
/
Progresión de la Enfermedad
/
Neoplasias Hepáticas
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
Clin Nucl Med
Año:
2020
Tipo del documento:
Article
País de afiliación:
Alemania